Salvatore De Marco
Azienda Ospedaliera San Camillo-Forlanini(IT)Carlo Forlanini Hospital(IT)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, COVID-19 Clinical Research Studies, Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations
Most-Cited Works
- → JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality(2020)215 cited
- → Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding(2020)139 cited
- Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemia.(1998)
- → Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study(2020)54 cited
- → Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?(2001)43 cited
- → Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19(2021)42 cited
- → Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers